105 related articles for article (PubMed ID: 28653903)
1. Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.
Lee J; Park HY; Kim WW; Lee SJ; Jeong JH; Kang SH; Jung JH; Chae YS
Tumour Biol; 2017 Jun; 39(6):1010428317707374. PubMed ID: 28653903
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.
Lee J; Jung JH; Chae YS; Park HY; Kim WW; Lee SJ; Jeong JH; Kang SH
Anticancer Res; 2016 Dec; 36(12):6289-6295. PubMed ID: 27919948
[TBL] [Abstract][Full Text] [Related]
3. Linc01638 Promotes Tumorigenesis in HER2+ Breast Cancer.
Liu P; Tang H; Wu J; Qiu X; Kong Y; Zhang L; Xie X; Xiao X
Curr Cancer Drug Targets; 2019; 19(1):74-80. PubMed ID: 29992881
[TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA HOXA11‑AS promotes cell proliferation and metastasis in human breast cancer.
Su JC; Hu XF
Mol Med Rep; 2017 Oct; 16(4):4887-4894. PubMed ID: 28791375
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.
Li Y; Jiang B; Zhu H; Qu X; Zhao L; Tan Y; Jiang Y; Liao M; Wu X
Tumour Biol; 2017 Jun; 39(6):1010428317705790. PubMed ID: 28635401
[TBL] [Abstract][Full Text] [Related]
6. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
Sun L; Li Y; Yang B
Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
[TBL] [Abstract][Full Text] [Related]
7. The MS-lincRNA landscape reveals a novel lincRNA BCLIN25 that contributes to tumorigenesis by upregulating ERBB2 expression via epigenetic modification and RNA-RNA interactions in breast cancer.
Xu S; Liu H; Wan L; Zhang W; Wang Q; Zhang S; Shang S; Zhang Y; Pang D
Cell Death Dis; 2019 Dec; 10(12):920. PubMed ID: 31801944
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NRON down-regulates lncRNA snaR and inhibits cancer cell proliferation in TNBC.
Niu L; Fan Q; Yan M; Wang L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996114
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer.
Fan S; Fan C; Liu N; Huang K; Fang X; Wang K
Mol Med Rep; 2018 May; 17(5):6405-6412. PubMed ID: 29532866
[TBL] [Abstract][Full Text] [Related]
10. Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
Milevskiy MJ; Al-Ejeh F; Saunus JM; Northwood KS; Bailey PJ; Betts JA; McCart Reed AE; Nephew KP; Stone A; Gee JM; Dowhan DH; Dray E; Shewan AM; French JD; Edwards SL; Clark SJ; Lakhani SR; Brown MA
Hum Mol Genet; 2016 Aug; 25(15):3269-3283. PubMed ID: 27378691
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of pluripotent long noncoding RNA ES3 in HER2-positive breast cancer.
Keshavarz M; Asadi MH; Riahi-Madvar A
J Cell Biochem; 2019 Oct; 120(10):18398-18405. PubMed ID: 31211468
[TBL] [Abstract][Full Text] [Related]
12. MIAT lncRNA is overexpressed in breast cancer and its inhibition triggers senescence and G1 arrest in MCF7 cell line.
Alipoor FJ; Asadi MH; Torkzadeh-Mahani M
J Cell Biochem; 2018 Aug; 119(8):6470-6481. PubMed ID: 29345338
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway.
Liu H; Wang G; Yang L; Qu J; Yang Z; Zhou X
PLoS One; 2016; 11(12):e0168406. PubMed ID: 27977766
[TBL] [Abstract][Full Text] [Related]
14. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer.
Kanematsu M; Futamura M; Takata M; Gaowa S; Yamada A; Morimitsu K; Morikawa A; Mori R; Hara H; Yoshida K
Cancer Med; 2015 Sep; 4(9):1344-55. PubMed ID: 26077887
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
[TBL] [Abstract][Full Text] [Related]
17. A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtype.
Cedro-Tanda A; Ríos-Romero M; Romero-Córdoba S; Cisneros-Villanueva M; Rebollar-Vega RG; Alfaro-Ruiz LA; Jiménez-Morales S; Domínguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Bautista-Piña V; Beltrán-Anaya FO; Hidalgo-Miranda A
Sci Rep; 2020 Aug; 10(1):13146. PubMed ID: 32753692
[TBL] [Abstract][Full Text] [Related]
18. The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Shi Y; Li J; Liu Y; Ding J; Fan Y; Tian Y; Wang L; Lian Y; Wang K; Shu Y
Mol Cancer; 2015 Feb; 14():51. PubMed ID: 25742952
[TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer.
Merry CR; McMahon S; Thompson CL; Miskimen KL; Harris LN; Khalil AM
Breast Cancer Res Treat; 2015 Apr; 150(2):321-34. PubMed ID: 25749757
[TBL] [Abstract][Full Text] [Related]
20. BMP9 inhibits proliferation and metastasis of HER2-positive SK-BR-3 breast cancer cells through ERK1/2 and PI3K/AKT pathways.
Ren W; Liu Y; Wan S; Fei C; Wang W; Chen Y; Zhang Z; Wang T; Wang J; Zhou L; Weng Y; He T; Zhang Y
PLoS One; 2014; 9(5):e96816. PubMed ID: 24805814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
